Wuhan General Gr Stock Fundamentals
| WUHNDelisted Stock | USD 0.0004 0.00 0.00% |
Wuhan General Gr fundamentals help investors to digest information that contributes to Wuhan General's financial success or failures. It also enables traders to predict the movement of Wuhan Pink Sheet. The fundamental analysis module provides a way to measure Wuhan General's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Wuhan General pink sheet.
Wuhan |
Wuhan General Gr Company Shares Outstanding Analysis
Wuhan General's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Wuhan General Shares Outstanding | 33.93 M |
Most of Wuhan General's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Wuhan General Gr is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Wuhan General Gr has 33.93 M of shares currently outstending. This is 81.21% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The shares outstanding for all United States stocks is 94.07% higher than that of the company.
Wuhan General Gr Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Wuhan General's current stock value. Our valuation model uses many indicators to compare Wuhan General value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Wuhan General competition to find correlations between indicators driving Wuhan General's intrinsic value. More Info.Wuhan General Gr is rated fourth in return on equity category among its peers. It is rated first in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Wuhan General by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Wuhan General's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Wuhan Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Wuhan General's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Wuhan General could also be used in its relative valuation, which is a method of valuing Wuhan General by comparing valuation metrics of similar companies.Wuhan General is currently under evaluation in shares outstanding category among its peers.
Wuhan Fundamentals
| Return On Equity | -0.0878 | ||||
| Return On Asset | -0.005 | ||||
| Profit Margin | (0.13) % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 3.05 M | ||||
| Shares Outstanding | 33.93 M | ||||
| Number Of Shares Shorted | 12.62 K | ||||
| Price To Earning | (0.06) X | ||||
| Price To Book | 0.04 X | ||||
| Price To Sales | 0.05 X | ||||
| Revenue | 80.38 M | ||||
| Gross Profit | 14.54 M | ||||
| EBITDA | 379.92 K | ||||
| Net Income | (10.59 M) | ||||
| Cash And Equivalents | 18.79 M | ||||
| Cash Per Share | 0.55 X | ||||
| Total Debt | 118.8 M | ||||
| Debt To Equity | 1.11 % | ||||
| Current Ratio | 1.10 X | ||||
| Book Value Per Share | 2.34 X | ||||
| Cash Flow From Operations | (21.86 M) | ||||
| Short Ratio | 0.15 X | ||||
| Earnings Per Share | (0.35) X | ||||
| Number Of Employees | 700 | ||||
| Beta | 1.94 | ||||
| Market Capitalization | 3.05 M | ||||
| Total Asset | 286.58 M | ||||
| Retained Earnings | 15 M | ||||
| Working Capital | 18 M | ||||
| Current Asset | 197 M | ||||
| Current Liabilities | 179 M | ||||
| Net Asset | 286.58 M |
About Wuhan General Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Wuhan General Gr's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Wuhan General using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Wuhan General Gr based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Wuhan General Group , Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol -based products under the Dr. Wuhan General Group , Inc. is headquartered in Pointe-Claire, Canada. Wuhan General operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 700 people.
Pair Trading with Wuhan General
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Wuhan General position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Wuhan General will appreciate offsetting losses from the drop in the long position's value.Moving together with Wuhan Pink Sheet
Moving against Wuhan Pink Sheet
| 0.72 | INIS | International Isotopes | PairCorr |
| 0.69 | YCBD-PA | cbdMD Inc | PairCorr |
| 0.67 | HROWM | Harrow Health, 11875 | PairCorr |
| 0.54 | ELTP | Elite Pharma | PairCorr |
| 0.38 | VAXX | Vaxxinity | PairCorr |
The ability to find closely correlated positions to Wuhan General could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Wuhan General when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Wuhan General - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Wuhan General Gr to buy it.
The correlation of Wuhan General is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Wuhan General moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Wuhan General Gr moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Wuhan General can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in Wuhan Pink Sheet
If you are still planning to invest in Wuhan General Gr check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Wuhan General's history and understand the potential risks before investing.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |